## KMX: CarMax Inc - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.57 indicates fundamental undervaluation. Caution: momentum weakening (-3.0% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($35.97)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Levi & Korsinsky Releases SueWallSt Podcast on CarMax, Inc. (KMX) Lawsuit**
- Source: Fox 59 | 20251208T130822 | Neutral | Relevance: 99%
- Levi & Korsinsky, LLP has released a podcast discussing a class action securities lawsuit filed against CarMax, Inc. (NYSE: KMX). The lawsuit alleges that CarMax made false and misleading statements about its growth prospects, which were reportedly a temporary benefit from customers buying cars due to tariff speculation. Investors who lost money between June 20, 2025, and November 5, 2025, are affected.

**2. Contact Levi & Korsinsky by January 2, 2026 Deadline to Join Class Action Against CarMax, Inc. (KMX)**
- Source: GlobeNewswire | 20251209T220844 | Neutral | Relevance: 99%
- Levi & Korsinsky, LLP has filed a class action lawsuit against CarMax, Inc. (KMX) on behalf of investors who suffered losses between June 20, 2025, and November 5, 2025. The lawsuit alleges that CarMax overstated its growth prospects, which were temporarily boosted by speculative car purchases related to tariffs. Investors have until January 2, 2026, to request to be appointed as lead plaintiff.

**3. CarMax, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - KMX**
- Source: PR Newswire | 20251208T140811 | Neutral | Relevance: 99%
- The Gross Law Firm has issued a notice to shareholders of CarMax, Inc. (NYSE: KMX) regarding alleged securities law violations. The firm encourages investors who purchased KMX shares between June 20, 2025, and November 5, 2025, to contact them, as the company is accused of overstating growth prospects. The deadline to seek lead plaintiff appointment in this class action is January 2, 2026.

**4. KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm**
- Source: WRIC ABC 8News | 20251208T000847 | Neutral | Relevance: 99%
-  The Rosen Law Firm reminds CarMax (NYSE: KMX) investors who purchased securities between June 20, 2025, and November 5, 2025, of the January 2, 2026, lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that CarMax overstated its growth prospects, which were temporarily inflated by tariff speculation, leading to investor damages. Investors are encouraged to contact the firm to potentially serve as lead plaintiff.

**5. CarMax, Inc. (KMX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit**
- Source: WRIC ABC 8News | 20251208T120822 | Neutral | Relevance: 99%
- Glancy Prongay & Murray LLP has announced a securities fraud class action lawsuit against CarMax, Inc. (NYSE: KMX), inviting investors who suffered losses to participate. The lawsuit alleges that CarMax overstated its growth prospects by failing to disclose that prior growth was a temporary benefit from customers buying cars due to tariff speculation. Investors have until January 2, 2026, to act as lead plaintiff.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $37 | $35 | +6% |
| 2025-11-18 | Wedbush | $40 | $40 | 0% |
| 2025-11-12 | Barclays | $28 | $0 | 0% |
| 2025-11-10 | Morgan Stanley | $35 | $56 | -38% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-11-18 | Wedbush | reit | Neutral |
| 2025-11-12 | Barclays | init | Underweight |
| 2025-11-10 | Morgan Stanley | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-3.8%)
- Blackrock Inc.: 7.8% (+5.9%)
- State Street Corpora: 3.8% (-2.2%)
- Janus Henderson Grou: 3.3% (+1.0%)
- Diamond Hill Capital: 3.3% (-30.6%)

### Key Risks

1. Elevated short interest (11.4%): bears positioning against stock.
2. Long-term trend broken: trading 34.1% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.57 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.5x). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.9B |
| Beta | 1.29 |
| 52W Range | $30.26 - $91.25 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.57 |
| Forward P/E | 13.4 |
| Current P/E | 15.1 |
| YoY Growth | 12.0% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 7.9% to 4.9% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 85th percentile. MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 7.1% shows strong absolute momentum above own 20MA. Outperforming sector by 5.8pp, stock-specific strength. Below SMA200 (0.66x), long-term trend not supportive. MACD histogram positive (0.76), confirming momentum. RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.91% (CS: 85) | Strong |
| RSI_14 | 52.9 | Neutral |
| MACD Histogram | 0.76 | Bullish |
| vs SMA20 | 1.071x | Above |
| vs SMA50 | 0.972x | Below |
| vs SMA200 | 0.659x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $39.03
- **Stop Loss:** $35.97 (7.8% risk)
- **Target:** $45.15 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 163
- **Position Value:** $6,361.89
- **Portfolio %:** 6.36%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2025-12-18 (Est: $0.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |
| 2024Q4 | $0.61 | $0.81 | +33.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*